LEI 894500UFIGC75NPZEZ68
BioVersys AG
Contract awards & public grants
Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new → BIOVERSYS AG
European Commission · CH · Grant · 2019-05-28
€6.93M
Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline → BIOVERSYS AG
European Commission · CH · Grant · 2019-05-08
€280,000
An integrated mulTidisciplinary appRoach towards a new generAtIon of aNtibiotics: Targeting function and cross-talk of bacterial Envelope proTein mach → BIOVERSYS AG
European Commission · CH · Grant · 2016-08-31
€265,227
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.